Juvenile Rheumatoid Arthritis (cont.)
What Medications Treat Juvenile Idiopathic Arthritis?
Nonsteroidal anti-inflammatory drugs
Disease-modifying antirheumatic drugs
- Methotrexate (Rheumatrex, Folex PFS): We do not know exactly how this drug works in treatment of inflammatory conditions. It relieves symptoms of inflammation such as pain, swelling, and stiffness. It may be given by injection if the oral form has little effect. Children taking methotrexate have to have regular blood tests to measure whether the drug is having any adverse effects on the liver or blood cells. It is the standard treatment for children with JIA in which joint damage is occurring.
- Sulfasalazine (Azulfidine): This drug decreases inflammatory responses by an effect similar to that of aspirin or NSAIDs.
- Gold salts (aurothiomalate, auranofin [Ridaura]): These compounds contain very tiny amounts of the metal gold. They can be taken by mouth or as injections. We do not know why they stop inflammation. Apparently the gold infiltrates into immune cells and interferes with their activities. Gold compounds, once widely used in JIA, are now rarely used in this disease.
- Azathioprine (Imuran): This drug stops production of cells that are part of the immune response that causes JIA. Unfortunately, it also stops production of some other types of cells and thus can have serious side effects. It very strongly suppresses the entire immune system and thus leaves the person vulnerable to infections and other problems. It is used only in very severe cases of JIA that have not gotten better with other DMARDs.
- Cyclosporin A (Neoral): This drug was developed for use in people undergoing organ transplantation. These people must have their immune system suppressed to prevent rejection of the transplant. Cyclosporin blocks an important immune cell and interferes with the immune response in several other ways. It is used most often in systemic JIA.
- Leflunomide (Arava): This drug blocks immune antibodies and reduces inflammation. It reduces symptoms and may even slow progression of JIA. This agent is not suitable for some people with kidney problems.
Biologic response modifiers
- Etanercept (Enbrel): This agent blocks the action of tumor necrosis factor, which in turn decreases inflammatory and immune responses. It is given by subcutaneous injection twice weekly.
- Infliximab (Remicade): This antibody blocks the action of tumor necrosis factor. It is usually used in combination with methotrexate in children whose JIA does not respond to methotrexate alone. It is given by intravenous infusion every six to eight weeks.
- Adalimumab (Humira): This is another blocker of tumor necrosis factor. It reduces inflammation and slows or stops worsening of joint damage in fairly severe JIA. This agent is used mainly for people whose JIA has not responded to at least two DMARDs. It is given by subcutaneous injection every other week.
- Anakinra (Kineret): This agent blocks the action of interleukin-1, which is partly responsible for the inflammation of JIA. This, in turn, blocks inflammation and pain. This agent usually is reserved for children whose JIA has not improved with DMARDs. It is given by subcutaneous injection daily.
- Abatacept (Orencia) is an agent that blocks the activation of an immune cell called the T cell. It was more recently FDA approved to treat children with JIA.
- Tocilizumab (Actemra) is a biologic agent which blocks the action of interleukin-6, which has a large role in the inflammation of JIA. It is FDA approved in polyarticular and systemic JIA.
- Clinical trials of the other biologic response modifiers are now being carried out to see whether these agents offer a benefit to children with JIA.
All medications have side effects, and the drugs used in JIA are no exceptions. Most studies of drug side effects are done in adults, and less is known about side effects in children. Side effects for a given drug may be much different in children than in adults. The medical professional who prescribes medication for a child with JIA should watch the child's response very carefully and adjust the dose accordingly. The goal is to find the proper balance between improving the child's condition and minimizing side effects.
Medically Reviewed by a Doctor on 5/11/2016
Must Read Articles Related to Juvenile Rheumatoid Arthritis
Iritis, or anterior uveitis, is an inflammation on the front part of the eye called the iris, which is the colored part of the eye that opens and closes the pup...learn more >>
Patient Comments & Reviews
The eMedicineHealth doctors ask about Juvenile Idiopathic Arthritis (Juvenile Rheumatoid Arthritis):